Akcea Therapeutics, Inc.
(NASDAQ : AKCA)

( )
AKCA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
-0.36%44.120.9%$1080.85m
JNJJohnson & Johnson
0.23%145.680.6%$1064.54m
MRKMerck & Co., Inc.
-0.24%74.680.6%$1011.37m
ABBVAbbVie, Inc.
1.00%89.682.2%$702.72m
BMYBristol-Myers Squibb Company
-1.01%52.851.4%$567.35m
LLYEli Lilly and Company
0.86%113.181.0%$507.03m
NVSNovartis AG Sponsored ADR
-1.09%88.250.2%$290.62m
AZNAstraZeneca PLC Sponsored ADR
-0.12%40.921.3%$191.95m
GSKGlaxoSmithKline plc Sponsored ADR
-0.63%41.040.2%$128.64m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.89%44.540.1%$68.21m
SNYSanofi Sponsored ADR
-2.22%44.580.2%$67.00m
LCILannett Company, Inc.
2.80%5.5137.0%$9.06m
AKTXAkari Therapeutics Plc Sponsored ADR
2.16%1.891.7%$0.06m
EPIXESSA Pharma Inc
9.45%3.190.1%$0.01m

Company Profile

Akcea Therapeutics, Inc. is a late-stage pharmaceutical company, which engages in the development and commercializing of drugs fro the treatment of cardio metabolic diseases caused by lipid disorders. Its products include novel drugs under the followng brands: volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA.